ancremonam (BOS-228) / Boston Pharma, Novartis - LARVOL DELTA

Anticancer activity and molecular docking of active ingredients from ethanolic extract of grapefruit peels against HepG2 cell. (PubMed, Sci Rep) - "Results Phytochemical screening revealed high phenolic and flavonoid content, with naringenin being the most abundant compound, followed by chlorogenic acid and ferulic acid...Interaction analysis revealed multiple hydrogen bonding and π-interactions with key AFP residues, including LYS228, CYS224, PHE172, GLU489, and MET490...Despite its lower potency compared to doxorubicin, it represents a valuable natural source of bioactive compounds. Further studies are required to elucidate its mechanisms, safety, and potential application in hepatocellular carcinoma therapy."

Journal • Hepatocellular Cancer • Oncology • Solid Tumor

New-generation antibiotics and non-antibiotic strategies against carbapenemase-producing Enterobacterales: More focus on metallo-β-lactamase producers. (PubMed, Int J Antimicrob Agents) - "Continued monitoring of resistance trends and the development of innovative therapeutic strategies is warranted in the ongoing battle against CPE harboring blaMBL."

Journal • Review • Infectious Disease

Molecular Informatics, Chemometrics, and Sensory Omics for Constructing an Umami Peptide Cluster Library Across the Entire Lager Beer Brewing Process. (PubMed, Foods) - "Salt-bridge or hydrogen-bond networks were formed around Lys228, Arg240, Glu206, Asp210, Asn141, and Gln138, thereby reducing conformational freedom...Umami peptide clusters were further proposed as a more appropriate functional unit, and an umami peptide cluster database spanning the full process was constructed. This database provided a reusable resource for process control and flavor prediction."

Journal